Reconsidering pluripotency tests: Do we still need teratoma assays?

Stem Cell Research

Volumn 11, Issue 1, 2013, Pages 552-562

  Buta, Christiane ^a   David, Robert ^b   Dressel, Ralf ^c   Emgård, Mia ^d   Fuchs, Christiane ^e   Gross, Ulrike ^f   Healy, Lyn ^g   Hescheler, Jürgen ^h   Kolar, Roman ^f   Martin, Ulrich ⁱ   Mikkers, Harald ^j   Müller, Franz Josef ^k   Schneider, Rebekka K ^l   Seiler, Andrea E M ^m   Spielmann, Horst ⁿ   Weitzer, Georg ^o  

^a SET Foundation   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY OF APPLIED SCIENCES TECHNIKUM WIEN   (Austria)

^f Akademie fur Tierschutz   (Germany)

^g UK Stem Cell Bank   (United Kingdom)

^h UNIVERSITY OF COLOGNE   (Germany)

ⁱ HANNOVER MEDICAL SCHOOL   (Germany)

^j LEIDEN UNIVERSITY   (Netherlands)

^k UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^l RWTH AACHEN UNIVERSITY   (Germany)

^m FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

ⁿ FREIE UNIVERSITÄT BERLIN   (Germany)

^o MEDICAL UNIVERSITY OF VIENNA   (Austria)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOASSAY; CARCINOGENICITY; CELL DIFFERENTIATION; CELL STRUCTURE; CHORIOALLANTOIS; EMBRYOID BODY; GOLD STANDARD; MACHINE LEARNING; NEURAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL RESEARCH; STEM CELL TRANSPLANTATION; TERATOMA; TERATOMA ASSAY; TUMOR GROWTH;

ANIMALS; BIOLOGICAL ASSAY; CELL DIFFERENTIATION; HUMANS; MICE; PLURIPOTENT STEM CELLS; TERATOMA;

ANIMALIA; MUS;

EID: 84876716219     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2013.03.001     Document Type: Review

References (77)

1. Andrews P.D., Becroft M., Aspegren A., Gilmour J., James M.J., McRae S., Kime R., Allcock R.W., Abraham A., Jiang Z., et al. High-content screening of feeder-free human embryonic stem cells to identify pro-survival small molecules. Biochem. J. 2010, 432:21-33.
2. Atkinson S., Armstrong L. Epigenetics in embryonic stem cells: regulation of pluripotency and differentiation. Cell Tissue Res. 2008, 331:23-29.
3. Bader A., Gruss A., Hollrigl A., Al-Dubai H., Capetanaki Y., Weitzer G. Paracrine promotion of cardiomyogenesis in embryoid bodies by LIF modulated endoderm. Differentiation 2001, 68:31-43.
4. Barbaric I., Gokhale P.J., Andrews P.W. High-content screening of small compounds on human embryonic stem cells. Biochem. Soc. Trans. 2010, 38:1046-1050.
5. Boland M.J., Hazen J.L., Nazor K.L., Rodriguez A.R., Gifford W., Martin G., Kupriyanov S., Baldwin K.K. Adult mice generated from induced pluripotent stem cells. Nature 2009, 461:91-94.
6. Borowiak M., Maehr R., Chen S., Chen A.E., Tang W., Fox J.L., Schreiber S.L., Melton D.A. Small molecules efficiently direct endodermal differentiation of mouse and human embryonic stem cells. Cell Stem Cell 2009, 4:348-358.
7. Boulting G.L., Kiskinis E., Croft G.F., Amoroso M.W., Oakley D.H., Wainger B.J., Williams D.J., Kahler D.J., Yamaki M., Davidow L., et al. A functionally characterized test set of human induced pluripotent stem cells. Nat. Biotechnol. 2011, 29:279-286.
8. Brazma A., Hingamp P., Quackenbush J., Sherlock G., Spellman P., Stoeckert C., Aach J., Ansorge W., Ball C.A., Causton H.C., et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat. Genet. 2001, 29:365-371.
9. Brivanlou A.H., Gage F.H., Jaenisch R., Jessell T., Melton D., Rossant J. Stem cells. Setting standards for human embryonic stem cells. Science 2003, 300:913-916.
10. Brolen G., Sivertsson L., Bjorquist P., Eriksson G., Ek M., Semb H., Johansson I., Andersson T.B., Ingelman-Sundberg M., Heins N. Hepatocyte-like cells derived from human embryonic stem cells specifically via definitive endoderm and a progenitor stage. J. Biotechnol. 2010, 145:284-294.
11. Cao R., Zhang Y. The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3. Curr. Opin. Genet. Dev. 2004, 14:155-164.
12. Chan E.M., Ratanasirintrawoot S., Park I.H., Manos P.D., Loh Y.H., Huo H., Miller J.D., Hartung O., Rho J., Ince T.A., et al. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat. Biotechnol. 2009, 27:1033-1037.
13. Damjanov I., Andrews P.W. The terminology of teratocarcinomas and teratomas. Nat. Biotechnol. 2007, 25:1212. (discussion 1212).
14. Dressel R. Effects of histocompatibility and host immune responses on the tumorigenicity of pluripotent stem cells. Semin. Immunopathol. 2011, 33:573-591.
15. Dressel R., Schindehutte J., Kuhlmann T., Elsner L., Novota P., Baier P.C., Schillert A., Bickeboller H., Herrmann T., Trenkwalder C., et al. The tumorigenicity of mouse embryonic stem cells and in vitro differentiated neuronal cells is controlled by the recipients' immune response. PLoS One 2008, 3:e2622.
16. Durupt F., Koppers-Lalic D., Balme B., Budel L., Terrier O., Lina B., Thomas L., Hoeben R.C., Rosa-Calatrava M. The chicken chorioallantoic membrane tumor assay as model for qualitative testing of oncolytic adenoviruses. Cancer Gene Ther. 2012, 19:58-68.
17. Eggan K., Akutsu H., Loring J., Jackson-Grusby L., Klemm M., Rideout W.M., Yanagimachi R., Jaenisch R. Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:6209-6214.
18. Elliott M.J., De Coppi P., Speggiorin S., Roebuck D., Butler C.R., Samuel E., Crowley C., McLaren C., Fierens A., Vondrys D., Cochrane L., Jephson C., Janes S., Beaumont N.J., Cogan T., Bader A., Seifalian A.M., Hsuan J.J., Lowdell M.W., Birchall M.A. Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study. Lancet 2012, 380:994-1000.
19. Erdö F., Buhrle C., Blunk J., Hoehn M., Xia Y., Fleischmann B., Focking M., Kustermann E., Kolossov E., Hescheler J., et al. Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke. J. Cereb. Blood Flow Metab. 2003, 23:780-785.
20. European Union, T.E.P.a.t.c.o.t. Directive 2010/63/EU on the protection of animals used for scientific purposes. Off. J. Eur. Union 2010, L276:33-79.
21. Evans M.J., Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981, 292:154-156.
22. Ferrari D., Binda E., De Filippis L., Vescovi A.L. Isolation of neural stem cells from neural tissues using the neurosphere technique. Curr. Protoc. Stem Cell Biol. 2010, (Chapter 2, Unit 2D 6).
23. Fong H., Hohenstein K.A., Donovan P.J. Regulation of self-renewal and pluripotency by Sox2 in human embryonic stem cells. Stem Cells 2008, 26:1931-1938.
24. Fuchs C., Scheinast M., Pasteiner W., Lagger S., Hofner M., Hoellrigl A., Schultheis M., Weitzer G. Self-organization phenomena in embryonic stem cell-derived embryoid bodies: axis formation and breaking of symmetry during cardiomyogenesis. Cells Tissues Organs 2012, 195:377-391.
25. Gertow K., Przyborski S., Loring J.F., Auerbach J.M., Epifano O., Otonkoski T., Damjanov I., Ahrlund-Richter L. Isolation of human embryonic stem cell-derived teratomas for the assessment of pluripotency. Curr. Protoc. Stem Cell Biol. 2007, (Chapter 1, Unit 1B 4).
26. Gertow K., Cedervall J., Jamil S., Ali R., Imreh M.P., Gulyas M., Sandstedt B., Ahrlund-Richter L. Early events in xenograft development from the human embryonic stem cell line HS181-resemblance with an initial multiple epiblast formation. PLoS One 2011, 6:e27741.
27. Gropp M., Shilo V., Vainer G., Gov M., Gil Y., Khaner H., Matzrafi L., Idelson M., Kopolovic J., Zak N.B., et al. Standardization of the teratoma assay for analysis of pluripotency of human ES cells and biosafety of their differentiated progeny. PLoS One 2012, 7:e45532.
28. Hagedorn M., Javerzat S., Gilges D., Meyre A., de Lafarge B., Eichmann A., Bikfalvi A. Accessing key steps of human tumor progression in vivo by using an avian embryo model. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:1643-1648.
29. Halbach M., Pillekamp F., Brockmeier K., Hescheler J., Müller-Ehmsen J., Reppel M. Ventricular slices of adult mouse hearts-a new multicellular in vitro model for electrophysiological studies. Cell. Physiol. Biochem. 2006, 18:1-8.
30. Halme D.G., Kessler D.A. FDA regulation of stem-cell-based therapies. N. Engl. J. Med. 2006, 355:1730-1735.
31. Hentze H., Soong P.L., Wang S.T., Phillips B.W., Putti T.C., Dunn N.R. Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies. Stem Cell Res. 2009, 2:198-210.
32. Houlard M., Berlivet S., Probst A.V., Quivy J.P., Hery P., Almouzni G., Gerard M. CAF-1 is essential for heterochromatin organization in pluripotent embryonic cells. PLoS Genet. 2006, 2:e181.
33. Höbaus J., Heher P., Gottschamel T., Scheinast M., Auner H., Walder D., Wiedner M., Taubenschmid J., Miksch M., Sauer T., et al. Embryonic stem cells facilitate the isolation of persistent clonal cardiovascular progenitor cell lines and leukemia inhibitor factor maintains their self-renewal and myocardial differentiation potential in vitro. Cells Tissues Organs 2013, 197:249-268.
34. ISCBI, T.I.S.C.B.I. Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes. Stem Cell Rev. 2009, 5:301-314.
35. Kang L., Wang J., Zhang Y., Kou Z., Gao S. iPS cells can support full-term development of tetraploid blastocyst-complemented embryos. Cell Stem Cell 2009, 5:135-138.
36. Kimura H., Tada M., Nakatsuji N., Tada T. Histone code modifications on pluripotential nuclei of reprogrammed somatic cells. Mol. Cell. Biol. 2004, 24:5710-5720.
37. Klochendler-Yeivin A., Fiette L., Barra J., Muchardt C., Babinet C., Yaniv M. The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression. EMBO Rep. 2000, 1:500-506.
38. Knoepfler P.S. Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine. Stem Cells 2009, 27:1050-1056.
39. Lagger S., Meunier D., Mikula M., Brunmeir R., Schlederer M., Artaker M., Pusch O., Egger G., Hagelkruys A., Mikulits W., et al. Crucial function of histone deacetylase 1 for differentiation of teratomas in mice and humans. EMBO J. 2010, 29:3992-4007.
40. Laustriat D., Gide J., Peschanski M. Human pluripotent stem cells in drug discovery and predictive toxicology. Biochem. Soc. Trans. 2010, 38:1051-1057.
41. Lawrenz B., Schiller H., Willbold E., Ruediger M., Muhs A., Esser S. Highly sensitive biosafety model for stem-cell-derived grafts. Cytotherapy 2004, 6:212-222.
42. Lee J.H., Hart S.R., Skalnik D.G. Histone deacetylase activity is required for embryonic stem cell differentiation. Genesis 2004, 38:32-38.
43. Li Z., Huang H., Boland P., Dominguez M.G., Burfeind P., Lai K.M., Lin H.C., Gale N.W., Daly C., Auerbach W., et al. Embryonic stem cell tumor model reveals role of vascular endothelial receptor tyrosine phosphatase in regulating Tie2 pathway in tumor angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:22399-22404.
44. Martin G.R., Evans M.J. Differentiation of clonal lines of teratocarcinoma cells: formation of embryoid bodies in vitro. Proc. Natl. Acad. Sci. U. S. A. 1975, 72:1441-1445.
45. Mauritz C., Martens A., Rojas S.V., Schnick T., Rathert C., Schecker N., Menke S., Glage S., Zweigerdt R., Haverich A., et al. Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction. Eur. Heart J. 2011, 32:2634-2641.
46. Medine C.N., Greenhough S., Hay D.C. Role of stem-cell-derived hepatic endoderm in human drug discovery. Biochem. Soc. Trans. 2010, 38:1033-1036.
47. Mitsui K., Tokuzawa Y., Itoh H., Segawa K., Murakami M., Takahashi K., Maruyama M., Maeda M., Yamanaka S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003, 113:631-642.
48. Müller F.J., Laurent L.C., Kostka D., Ulitsky I., Williams R., Lu C., Park I.H., Rao M.S., Shamir R., Schwartz P.H., et al. Regulatory networks define phenotypic classes of human stem cell lines. Nature 2008, 455:401-405.
49. Müller F.J., Goldmann J., Loser P., Loring J.F. A call to standardize teratoma assays used to define human pluripotent cell lines. Cell Stem Cell 2010, 6:412-414.
50. Müller F.J., Schuldt B.M., Williams R., Mason D., Altun G., Papapetrou E.P., Danner S., Goldmann J.E., Herbst A., Schmidt N.O., et al. A bioinformatic assay for pluripotency in human cells. Nat. Methods 2011, 8:315-317.
51. Nagy A., Gocza E., Diaz E.M., Prideaux V.R., Ivanyi E., Markkula M., Rossant J. Embryonic stem cells alone are able to support fetal development in the mouse. Development 1990, 110:815-821.
52. Ott H.C., Taylor D.A. From cardiac repair to cardiac regeneration-ready to translate?. Expert Opin. Biol. Ther. 2006, 6:867-878.
53. Pesce M., Scholer H.R. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 2001, 19:271-278.
54. Peterson S.E., Tran H.T., Garitaonandia I., Han S., Nickey K.S., Leonardo T., Laurent L.C., Loring J.F. Teratoma generation in the testis capsule. J. Vis. Exp. 2011, e3177. (http://www.jove.com/video/3177/teratoma-generation-in-the-testis-capsule).
55. Rossant J. Stem cells and early lineage development. Cell 2008, 132:527-531.
56. Russell W.M.S., Burch R.L. The Principles of Humane Experimental Technique 1959, Methuen, London.
57. Saric T., Frenzel L.P., Hescheler J. Immunological barriers to embryonic stem cell-derived therapies. Cells Tissues Organs 2008, 188:78-90.
58. Siegel N., Rosner M., Unbekandt M., Fuchs C., Slabina N., Dolznig H., Davies J.A., Lubec G., Hengstschlager M. Contribution of human amniotic fluid stem cells to renal tissue formation depends on mTOR. Hum. Mol. Genet. 2010, 19:3320-3331.
59. Skreb N., Svajger A., Levak-Svajger B. Growth and differentiation of rat egg-cylinders under the kidney capsule. J. Embryol. Exp. Morphol. 1971, 25:47-56.
60. Solter D., Skreb N., Damjanov I. Extrauterine growth of mouse egg-cylinders results in malignant teratoma. Nature 1970, 227:503-504.
61. Stadtfeld M., Hochedlinger K. Induced pluripotency: history, mechanisms, and applications. Genes Dev. 2010, 24:2239-2263.
62. Stadtfeld M., Apostolou E., Akutsu H., Fukuda A., Follett P., Natesan S., Kono T., Shioda T., Hochedlinger K. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 2010, 465:175-181.
63. Stevens L.C. Studies on transplantable testicular teratomas of strain 129 mice. J. Natl. Cancer Inst. 1958, 20:1257-1275.
64. Stevens L.C. The development of transplantable teratocarcinomas from intratesticular grafts of pre- and postimplantation mouse embryos. Dev. Biol. 1970, 21:364-382.
65. Stevens L.C., Little C.C. Spontaneous testicular teratomas in an inbred strain of mice. Proc. Natl. Acad. Sci. U. S. A. 1954, 40:1080-1087.
66. Studer L. Stem cells with brainpower. Nat. Biotechnol. 2001, 19:1117-1118.
67. Swiss Federal Veterinary Office (Hsrg) Classification of Animal Experiments according to Grades of Severity prior to the Experiment (Stress Categories) 2012, (http://www.tierversuch.ch/show=AWLaw&nav_id4104&lang=en (02.14.2012)).
68. Taubenschmid J., Weitzer G. Mechanisms of cardiogenesis in cardiovascular progenitor cells. Int. Rev. Cell Mol. Biol. 2012, 293:195-267.
69. Unbekandt M., Davies J.A. Dissociation of embryonic kidneys followed by reaggregation allows the formation of renal tissues. Kidney Int. 2010, 77:407-416.
70. Verhoog H. The concept of intrinsic value and transgenic animals. J. Agric. Ethics 1992, 5:147-160.
71. Vorstenbosch J. The concept of integrity. Its significance for the ethical discussion on biotechnology and animals. Livest. Prod. Sci. 1993, 36:109-112.
72. Weitzer G. Embryonic stem cell-derived embryoid bodies: an in vitro model of eutherian pregastrulation development and early gastrulation. Handb. Exp. Pharmacol. 2006, 21-51.
73. Wesselschmidt R.L. The teratoma assay: an in vivo assessment of pluripotency. Methods Mol. Biol. 2011, 767:231-241.
74. Williams R., Schuldt B., Müller F.J. A guide to stem cell identification: progress and challenges in system-wide predictive testing with complex biomarkers. Bioessays 2011, 33:880-890.
75. Wobus A.M., Holzhausen H., Jakel P., Schoneich J. Characterization of a pluripotent stem cell line derived from a mouse embryo. Exp. Cell Res. 1984, 152:212-219.
76. Zhao X.Y., Li W., Lv Z., Liu L., Tong M., Hai T., Hao J., Guo C.L., Ma Q.W., Wang L., et al. iPS cells produce viable mice through tetraploid complementation. Nature 2009, 461:86-90.
77. Zhu S., Wurdak H., Wang J., Lyssiotis C.A., Peters E.C., Cho C.Y., Wu X., Schultz P.G. A small molecule primes embryonic stem cells for differentiation. Cell Stem Cell 2009, 4:416-426.